Patents by Inventor Michael Monrad

Michael Monrad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170290988
    Abstract: A drug delivery device (100) for estimating the amount of free air in a cartridge (1) comprising a cartridge receiving portion (not shown) adapted to receive a cartridge (1), the cartridge (1) comprising a body portion (6), an axially displaceable piston (5), and a distal outlet portion (4), an expelling assembly comprising an axially displaceable piston drive member (10) adapted to interface with the proximal piston (5) portion of a received cartridge (1), the piston drive member (10) is adapted to be moveable in a distal direction, and to thereby pressurize the drug in a received cartridge. The drug delivery device further comprises means for measuring and acquiring a property relating to a fluid pres-sure of the drug in a received cartridge (1), and where the property depends on the amount of free air (7) contained in the cartridge (1).
    Type: Application
    Filed: September 1, 2015
    Publication date: October 12, 2017
    Inventors: Michael Monrad, Jens Aage Munk, Per Einar Pontus Holm, Dan Noertoft Soerensen
  • Patent number: 9734302
    Abstract: A drug delivery system comprising a controller adapted to detect when a given user-actuated operation being part of the expelling of an amount of drug is performed, record detected operations as a function of time, and estimate, based on recorded operations, time parameters for the detected operations, thereby providing time parameters for a medical regimen on which the detected operations are assumed to be based upon.
    Type: Grant
    Filed: April 17, 2013
    Date of Patent: August 15, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Ole C. Nielsen, Michael Monrad, Mads Moeller, Torkil Filholm
  • Patent number: 9675761
    Abstract: A drug delivery system (1) comprising first (35) and second reservoir units (30) with first and second identifiers (32), and a main unit (10) adapted to receive either of the first (35) and second reservoir units (30) in a mounted position. The main unit (10) comprises drug expelling means having dose setting means (11, 1, 14, 15, 19) comprising a rotational dose setting member allowing a user to set a desired dose size for the given drug, the dose size being set in fixed increments for a given state. The drug expelling means has a first state in which an increment corresponds to a first volume of drug, and a second state in which an increment corresponds to a second volume of drug, wherein the drug expelling means is set in the first state by means of the first identifier when a first reservoir unit is mounted, and the drug expelling means is set in the second state by means of the second identifier when a second reservoir unit is mounted.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: June 13, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Jesper Hoeholt, Michael Monrad, Carsten Schau Andersen, Mikkel Schouenborg Grubbe, Bennie Peder Smiszek Pedersen
  • Publication number: 20170151388
    Abstract: A drug delivery device comprising a piston rod adapted to engage and axially move a cartridge piston to thereby expel an amount of drug from a loaded cartridge corresponding to a set dose amount, the device comprising a motor for moving the drive member from an initial position, through a start-of-dose position, to an end-of-dose position, as well as position detection means adapted to generate output data indicative of the drive member's position relative to the piston of a loaded cartridge. An electronic controller adapted is adapted operate the motor to continuously move the drive member from the initial position, based on output data from the position detection means determine that the drive member is in engagement with the cartridge piston corresponding to the start-of-dose position, and operate the motor to move the drive member from the start-of-dose position to the an end-of-dose position corresponding to the set dose.
    Type: Application
    Filed: July 8, 2015
    Publication date: June 1, 2017
    Applicants: Novo Nordisk A/S, Novo Nordisk A/S
    Inventors: Michael Monrad, Per Einar Pontus Holm, Jens Aage Munk
  • Patent number: 9636462
    Abstract: A drug delivery device comprises a shield (30) moveably mounted to a main portion and being displaceable by a user between a shielding and a non-shielding position, wherein a needle assembly (50) can be mounted on a reservoir, the shield covering the needle assembly in the shielding position. The needle assembly is moveable between a dis-connected and connected position in fluid communication with the reservoir. In such an arrangement a mounted needle assembly is moved from the dis-connected to the connected position when the shield is moved from the shielding to the non-shielding position, and moved from the connected to the dis-connected position when the shield is moved from the non-shielding to the shielding position.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: May 2, 2017
    Assignee: Novo Nordisk A/S
    Inventors: Michael Monrad, Jesper Hoeholt, Bennie P. S. Pedersen, Carsten S. Andersen
  • Publication number: 20150343146
    Abstract: A drug delivery device comprises a shield (30) moveably mounted to a main portion and being displaceable by a user between a shielding and a non-shielding position, wherein a needle assembly (50) can be mounted on a reservoir, the shield covering the needle assembly in the shielding position. The needle assembly is moveable between a dis-connected and connected position in fluid communication with the reservoir. In such an arrangement a mounted needle assembly is moved from the dis-connected to the connected position when the shield is moved from the shielding to the non-shielding position, and moved from the connected to the dis-connected position when the shield is moved from the non-shielding to the shielding position.
    Type: Application
    Filed: November 4, 2013
    Publication date: December 3, 2015
    Inventors: Michael Monrad, Jesper Hoeholt, Bennie P. S. Pedersen, Carsten S. Andersen
  • Publication number: 20150297835
    Abstract: A drug delivery system (1) comprising first (35) and second reservoir units (30) with first and second identifiers (32), and a main unit (10) adapted to receive either of the first (35) and second reservoir units (30) in a mounted position. The main unit (10) comprises drug expelling means having dose setting means (11, 1, 14, 15, 19) comprising a rotational dose setting member allowing a user to set a desired dose size for the given drug, the dose size being set in fixed increments for a given state. The drug expelling means has a first state in which an increment corresponds to a first volume of drug, and a second state in which an increment corresponds to a second volume of drug, wherein the drug expelling means is set in the first state by means of the first identifier when a first reservoir unit is mounted, and the drug expelling means is set in the second state by means of the second identifier when a second reservoir unit is mounted.
    Type: Application
    Filed: November 19, 2013
    Publication date: October 22, 2015
    Inventors: Jesper Hoeholt, Michael Monrad, Carsten Schau Andersen, Mikkel Schouenborg Grubbe, Bennie Peder Smiszek Pedersen
  • Publication number: 20150066429
    Abstract: A drug delivery system comprising a controller adapted to detect when a given user-actuated operation being part of the expelling of an amount of drug is performed, record detected operations as a function of time, and estimate, based on recorded operations, time parameters for the detected operations, thereby providing time parameters for a medical regimen on which the detected operations are assumed to be based upon.
    Type: Application
    Filed: April 17, 2013
    Publication date: March 5, 2015
    Applicant: Novo Nordisk A/S
    Inventors: Ole C. Nielsen, Michael Monrad, Mads Moeller, Torkil Filholm